Andlauer Healthcare Group Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Michael Andlauer

Chief Executive Officer (CEO)

CA$1.0m

Compensación total

Porcentaje del salario del CEO	49.5%
Permanencia del CEO	5yrs
Participación del CEO	n/a
Permanencia media de la dirección	1.5yrs
Promedio de permanencia en la Junta Directiva	5yrs

Actualizaciones recientes de la dirección

Recent updates

We Think Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt With Ease

Nov 07

Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Oct 17

Andlauer Healthcare Group (TSE:AND) Is Increasing Its Dividend To CA$0.11

Sep 20

Here's Why Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt Responsibly

May 23

These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Reasonably Well

Jan 30

Return Trends At Andlauer Healthcare Group (TSE:AND) Aren't Appealing

Aug 24

Market Participants Recognise Andlauer Healthcare Group Inc.'s (TSE:AND) Earnings

May 05

We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Oct 28

These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Safely

Oct 12

Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Aug 17

We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Jul 19

Andlauer Healthcare Group (TSE:AND) Could Easily Take On More Debt

Jul 05

The Returns At Andlauer Healthcare Group (TSE:AND) Aren't Growing

May 04

I Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Apr 19

Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?

Feb 23

Is There An Opportunity With Andlauer Healthcare Group Inc.'s (TSE:AND) 33% Undervaluation?

Jan 19

We Think Andlauer Healthcare Group (TSE:AND) Might Have The DNA Of A Multi-Bagger

Jan 06

Should You Be Adding Andlauer Healthcare Group (TSE:AND) To Your Watchlist Today?

Dec 15

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Michael Andlauer en comparación con los beneficios de Andlauer Healthcare Group?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2024	n/a	n/a	CA$66m
Jun 30 2024	n/a	n/a	CA$65m
Mar 31 2024	n/a	n/a	CA$65m
Dec 31 2023	CA$1m	CA$500k	CA$66m
Sep 30 2023	n/a	n/a	CA$67m
Jun 30 2023	n/a	n/a	CA$71m
Mar 31 2023	n/a	n/a	CA$76m
Dec 31 2022	CA$872k	CA$387k	CA$76m
Sep 30 2022	n/a	n/a	CA$110m
Jun 30 2022	n/a	n/a	CA$103m
Mar 31 2022	n/a	n/a	CA$95m
Dec 31 2021	CA$853k	CA$360k	CA$90m
Sep 30 2021	n/a	n/a	CA$51m
Jun 30 2021	n/a	n/a	CA$47m
Mar 31 2021	n/a	n/a	CA$41m
Dec 31 2020	CA$763k	CA$360k	CA$38m
Sep 30 2020	n/a	n/a	CA$31m
Jun 30 2020	n/a	n/a	CA$30m
Mar 31 2020	n/a	n/a	CA$31m
Dec 31 2019	CA$173k	CA$21k	CA$30m

Compensación vs. Mercado: La compensación total de Michael($USD723.07K) está por debajo de la media de empresas de tamaño similar en el mercado Canadian ($USD2.02M).

Compensación vs. Ingresos: La compensación de Michael ha sido consistente con los resultados de la empresa en el último año.

CEO

Michael Andlauer (59 yo)

5yrs

Permanencia

CA$1,010,000

Compensación

Mr. Michael N. Andlauer serves as Chief Executive Officer at Andlauer Healthcare Group Inc. and its Director since November 12, 2019. He was President at Andlauer Healthcare Group Inc. He is the Founder an...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Michael Andlauer	CEO & Director	no data	CA$1.01m	sin datos
Peter Bromley	CFO & Corporate Secretary	no data	CA$799.50k	0.042% CA$ 710.0k
Charles Brogan	President of Specialty Solutions	no data	CA$799.50k	0% CA$ 0
Dean Berg	President of Logistics	3.4yrs	CA$682.50k	0.052% CA$ 878.4k
Graham Cromb	Chief Strategy Officer	1.5yrs	sin datos	0.0025% CA$ 41.8k
Sandro Caccaro	President of Transportation	less than a year	sin datos	sin datos

1.5yrs

Permanencia media

60yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de AND no se considera experimentado ( 1.5 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Michael Andlauer	CEO & Director	5yrs	CA$1.01m	sin datos
Evelyn Sutherland	Independent Non-Executive Director	5yrs	CA$95.51k	0.051% CA$ 855.4k
Thomas Wellner	Independent Non-Executive Director	5yrs	CA$92.95k	0.017% CA$ 282.3k
Cameron Joyce	Independent Non-Executive Director	5yrs	CA$77.47k	0.24% CA$ 4.0m
Ronalee Ambrose	Lead Independent Director	5yrs	CA$108.24k	0.033% CA$ 551.7k
Joseph Schlett	Independent Non-Executive Director	5yrs	CA$87.35k	0.0085% CA$ 142.7k
Peter Jelley	Chairman of the Board	5yrs	CA$103.29k	0.48% CA$ 8.0m

5.0yrs

Permanencia media

59yo

Promedio de edad

Junta con experiencia: La junta directiva de AND se considera experimentada (5 años de antigüedad promedio).

Andlauer Healthcare Group Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Insider recently sold CA$887k worth of stock

President of Specialty Solutions recently sold CA$211k worth of stock

Chairman of the Board recently sold CA$970k worth of stock

President of Specialty Solutions recently sold CA$791k worth of stock

Chairman of the Board exercised options to buy CA$3.8m worth of stock.

President of Specialty Solutions exercised options to buy CA$1.3m worth of stock.

Recent updates

Insider recently sold CA$887k worth of stock

We Think Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt With Ease

Third quarter 2024 earnings released: EPS: CA$0.41 (vs CA$0.37 in 3Q 2023)

Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Andlauer Healthcare Group Inc. to Report Q3, 2024 Results on Nov 05, 2024

Andlauer Healthcare Group (TSE:AND) Is Increasing Its Dividend To CA$0.11

Second quarter dividend of CA$0.11 announced

Andlauer Healthcare Announces Third Quarter Dividend, Payable on October 15, 2024

President of Specialty Solutions recently sold CA$211k worth of stock

Second quarter 2024 earnings released: EPS: CA$0.38 (vs CA$0.38 in 2Q 2023)

Andlauer Healthcare Group Inc. to Report Q2, 2024 Results on Jul 31, 2024

Chairman of the Board recently sold CA$970k worth of stock

First quarter dividend of CA$0.10 announced

Andlauer Healthcare Announces Second Quarter Dividend, Payable on July 15, 2024

President of Specialty Solutions recently sold CA$791k worth of stock

Chairman of the Board exercised options to buy CA$3.8m worth of stock.

Here's Why Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt Responsibly

Andlauer Healthcare Group Inc. (TSX:AND) announces an Equity Buyback for 2,000,000 shares, representing 4.8% for CAD 90 million.

President of Specialty Solutions exercised options to buy CA$1.3m worth of stock.

First quarter 2024 earnings released: EPS: CA$0.36 (vs CA$0.39 in 1Q 2023)

Andlauer Healthcare Group Inc. to Report Q1, 2024 Results on May 02, 2024

Fourth quarter dividend of CA$0.10 announced

Andlauer Healthcare Group Inc. Provides Quarterly Dividend Guidance

Full year 2023 earnings released: EPS: CA$1.58 (vs CA$1.82 in FY 2022)

Andlauer Healthcare Group Inc., Annual General Meeting, May 03, 2024

Andlauer Healthcare Group Inc. to Report Q4, 2023 Results on Mar 05, 2024

These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Reasonably Well

Andlauer Healthcare Group Inc. Announces Board Changes

Chairman of the Board recently bought CA$768k worth of stock

Chairman of the Board recently sold CA$774k worth of stock

Third quarter 2023 earnings released: EPS: CA$0.37 (vs CA$0.45 in 3Q 2022)

Andlauer Healthcare Group Inc. to Report Q3, 2023 Results on Nov 02, 2023

Upcoming dividend of CA$0.09 per share at 0.8% yield

Andlauer Healthcare Group Inc. Announces the Third Quarter Shareholder Dividend, Payable on October 16, 2023

Return Trends At Andlauer Healthcare Group (TSE:AND) Aren't Appealing

Andlauer Healthcare Group Inc. Intends to Declare Quarterly Dividend

Second quarter 2023 earnings released: EPS: CA$0.37 (vs CA$0.50 in 2Q 2022)

Andlauer Healthcare Group Inc. to Report Q2, 2023 Results on Aug 01, 2023

Andlauer Healthcare Group Inc. Announces Dividend for the Second Quarter Period from April 1, 2023 to June 30, 2023, Payable on July 17, 2023

Insider recently sold CA$9.8m worth of stock

Insider recently sold CA$242k worth of stock

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

First quarter 2023 earnings released: EPS: CA$0.39 (vs CA$0.40 in 1Q 2022)

Andlauer Healthcare Group Inc. Appoints Graham Cromb as Chief Strategy Officer

Market Participants Recognise Andlauer Healthcare Group Inc.'s (TSE:AND) Earnings

Is Andlauer Healthcare Group (TSE:AND) Using Too Much Debt?

President of Transportation recently sold CA$709k worth of stock

Upcoming dividend of CA$0.08 per share at 0.6% yield

Full year 2022 earnings released: EPS: CA$1.82 (vs CA$2.30 in FY 2021)

Andlauer Healthcare Group Inc., Annual General Meeting, May 04, 2023

Andlauer Healthcare Group Inc. to Report Q4, 2022 Results on Mar 02, 2023

President of Transportation recently sold CA$243k worth of stock

A Look At The Fair Value Of Andlauer Healthcare Group Inc. (TSE:AND)

Andlauer Healthcare Group Inc. Announces Fourth Quarter Dividend, Payable on January 16, 2023

Andlauer Healthcare Group (TSE:AND) Hasn't Managed To Accelerate Its Returns

Insider recently sold CA$595k worth of stock

Insufficient new directors

Third quarter 2022 earnings released: EPS: CA$0.45 (vs CA$0.32 in 3Q 2021)

We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Andlauer Healthcare Group Inc. to Report Q3, 2022 Results on Nov 08, 2022

These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Safely

Andlauer Healthcare Group Inc. Announces Dividend for the Period from July 1, 2022 to September 30, 2022, Payable on October 17, 2022

Insider recently sold CA$358k worth of stock

President of Specialty Solutions recently sold CA$448k worth of stock

Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Investor sentiment improved over the past week

Price target increased to CA$57.83

Second quarter 2022 earnings released